Evidence map›Paper›PMID 34958390›Full record

ReviewThe Journal of nutrition2022

Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy.

Scott M Ebert, Blake B Rasmussen, Andrew R Judge, Sarah M Judge, Lars Larsson, Ronald C Wek, Tracy G Anthony, George R Marcotte, Matthew J Miller, Mark A Yorek and 7 more

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Metformin Partially Attenuates Simvastatin-Induced Myotoxic Responses in C2C12 Myotubes Through Metabolic Adaptation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Muscle-specific Keap1 deletion enhances force production but does not prevent inactivity-induced muscle atrophy in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Unzipping the defense: a comprehensive review on bZIP transcription factors inFrontiers in cellular and infection microbiology · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Scott M EbertDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
Blake B RasmussenEmmyon, Inc., Rochester, MN, USA.
Andrew R JudgeEmmyon, Inc., Rochester, MN, USA.
Sarah M JudgeDepartment of Physical Therapy, University of Florida, Gainesville, FL, USA.
Lars LarssonDepartment of Physiology and Pharmacology, Karolinska, Stockholm, Sweden.
Ronald C WekDepartment of Biochemistry and Molecular Biology, Indiana University, Indianapolis, IN, USA.
Tracy G AnthonyDepartment of Nutritional Sciences, Rutgers University, New Brunswick, NJ, USA.
George R MarcotteDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
Matthew J MillerDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
Mark A YorekDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Adrian VellaDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-6493-7837
Elena VolpiDepartment of Nutrition, Metabolism and Rehabilitation Sciences, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0001-8776-0384
Jennifer I SternDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
Matthew D StrubDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
Zachary RyanDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
John J TalleyEmmyon, Inc., Rochester, MN, USA.
Christopher M AdamsDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USUniversity of Iowa · USThe University of Texas Medical Branch at Galveston · USUniversity of Florida · USIndiana University – Purdue University Indianapolis · USRutgers, The State University of New Jersey · US

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
DIABETES AND METABOLISMT32DK007352 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1986 to 2026
$9.4M
The regulation of fasting glucose metabolism in people with and without prediabetesR01DK078646 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2007 to 2026
$8.7M
Medical Scientist Training ProgramT32GM139776 · NIGMS · UNIVERSITY OF IOWA · PI Gordon F Buchanan · 2021 to 2026
$6.4M
Glucagon suppression and diabetes-associated variation in TCF7L2R01DK116231 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2017 to 2026
$5.4M
Homeostatic Responses to Amino Acid InsufficiencyR01DK109714 · NIDDK · RUTGERS, THE STATE UNIV OF N.J. · PI ANTHONY, TRACY G., WEK, RONALD C · 2016 to 2024
$5.4M
FOXO signaling and skeletal muscle atrophyR01AR060209 · NIAMS · UNIVERSITY OF FLORIDA · PI JUDGE, ANDREW ROBERT · 2011 to 2021
$4.2M
The effect of endogenous GLP-1 secretion on islet function in vivoR01DK126206 · NIDDK · MAYO CLINIC ROCHESTER · PI Adrian Vella · 2020 to 2026
$4.0M
Novel Signaling Pathways Underlying Skeletal Muscle AtrophyR01AG060637 · NIA · UNIVERSITY OF IOWA · PI ADAMS, CHRISTOPHER M · 2018 to 2022
$2.6M
Molecular pathogenesis of skeletal muscle atrophyR01AR071762 · NIAMS · UNIVERSITY OF IOWA · PI ADAMS, CHRISTOPHER M · 2017 to 2021
$2.4M
Development of Novel Small Molecule Therapies for Skeletal Muscle AtrophyR44AG047684 · NIA · EMMYON, INC. · PI ADAMS, CHRISTOPHER M, EBERT, SCOTT MATTHEW · 2018 to 2019
$1.5M
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle AtrophyR44AR069400 · NIAMS · EMMYON, INC. · PI ADAMS, CHRISTOPHER M, EBERT, SCOTT MATTHEW · 2020 to 2021
$1.5M
BLRD VA I01 BX000976NIAMS NIH HHS R01 AR060209NIAMS NIH HHS R01 AR071762NIAMS NIH HHS R44 AR069400NIA NIH HHS P30 AG024832NIA NIH HHS R01 AG060637NIA NIH HHS R44 AG047684NIDDK NIH HHS R01 DK078646NIDDK NIH HHS R01 DK109714NIDDK NIH HHS R01 DK116231NIDDK NIH HHS R01 DK126206NIDDK NIH HHS T32 DK007352NIGMS NIH HHS T32 GM139776
6 · The paper itself

Abstract

Activating transcription factor 4 (ATF4) is a multifunctional transcription regulatory protein in the basic leucine zipper superfamily. ATF4 can be expressed in most if not all mammalian cell types, and it can participate in a variety of cellular responses to specific environmental stresses, intracellular derangements, or growth factors. Because ATF4 is involved in a wide range of biological processes, its roles in human health and disease are not yet fully understood. Much of our current knowledge about ATF4 comes from investigations in cultured cell models, where ATF4 was originally characterized and where further investigations continue to provide new insights. ATF4 is also an increasingly prominent topic of in vivo investigations in fully differentiated mammalian cell types, where our current understanding of ATF4 is less complete. Here, we review some important high-level concepts and questions concerning the basic biology of ATF4. We then discuss current knowledge and emerging questions about the in vivo role of ATF4 in one fully differentiated cell type, mammalian skeletal muscle fibers.

Indexed as

Activating Transcription Factor 4Muscular AtrophyAnimalsBiologyCell DifferentiationHumansMammalsMuscle Fibers, SkeletalActivating Transcription Factor 4ATF4 protein, humanATF4sarcopeniaskeletal muscle atrophytomatidineursolic acid

Identifiers

PMID34958390
PMCPMC8970988
OpenAlexW4200521246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.